Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2011, Article ID 841407, 10 pages
Review Article

Management of Hepatic Encephalopathy

1University College London Institute of Hepatology, The Royal Free Hospital, Pond Street, London NW3 2PF, UK
2Department of Gastroenterology, King Georges Hospital, Barley Lane, Goodmayes, Ilford, Essex IG3 8YB, UK

Received 28 April 2011; Accepted 8 June 2011

Academic Editor: Deepak Amarapurkar

Copyright © 2011 G. Wright et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Matteo Garcovich, Maria Assunta Zocco, Davide Roccarina, Francesca Romana Ponziani, and Antonio Gasbarrini, “Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota,” World Journal Of Gastroenterology, vol. 18, no. 46, pp. 6693–6700, 2012. View at Publisher · View at Google Scholar
  • Amara Aït-Aissa, and Mohammed Aïder, “Lactulose: production and use in functional food, medical and pharmaceutical applications. Practical and critical review,” International Journal of Food Science & Technology, 2013. View at Publisher · View at Google Scholar
  • Susan Victoria Beath, “End stage liver disease,” Paediatrics and Child Health, vol. 23, no. 12, pp. 535–544, 2013. View at Publisher · View at Google Scholar
  • Halina Cichoż-Lach, and Agata Michalak, “Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy.,” World journal of gastroenterology, vol. 19, no. 1, pp. 26–34, 2013. View at Publisher · View at Google Scholar
  • M. K. Unnikrishnan, M. Sonal Sekhar, Gabriel Sunil Rodrigues, and Chiranjay Mukhopadhyay, “Synbiotic formulation of probiotic and lactulose combination for hepatic encephalopathy treatment: A realistic hope?,” Medical Hypotheses, vol. 81, no. 2, pp. 167–168, 2013. View at Publisher · View at Google Scholar
  • Jun Xu, Rui Ma, Li-Feng Chen, Li-Jun Zhao, Kan Chen, and Ren-Bing Zhang, “Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: an updated meta-analysis of six randomized controlled trials,” Hepatobiliary & Pancreatic Diseases International, vol. 13, no. 4, pp. 354–360, 2014. View at Publisher · View at Google Scholar
  • Ahmad Parvinian, James T. Bui, M. Grace Knuttinen, Jeet Minocha, and Ron C. Gaba, “Transjugular intrahepatic portosystemic shunt for the treatment of medically refractory ascites,” Diagnostic and Interventional Radiology, vol. 20, no. 1, pp. 58–64, 2014. View at Publisher · View at Google Scholar
  • Robert S. Rahimi, and Don C. Rockey, “Overuse of Head Computed Tomography in Cirrhosis With Altered Mental Status,” The American Journal of the Medical Sciences, vol. 351, no. 5, pp. 459–466, 2016. View at Publisher · View at Google Scholar
  • Kenji Ikeda, Masatoshi Kudo, Seiji Kawazoe, Yukio Osaki, Masafumi Ikeda, Takuji Okusaka, Toshiyuki Tamai, Takuya Suzuki, Takashi Hisai, Seiichi Hayato, Kiwamu Okita, and Hiromitsu Kumada, “Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma,” Journal of Gastroenterology, 2016. View at Publisher · View at Google Scholar